| Q2 FY26 | YoY | 6M FY26 | |
|---|---|---|---|
| Revenue | $106.1B | +7.3% | $206.5B |
| Net income | $3.0B | 0.0% | – |
| Op income | $4.7B | 0.0% | – |
| EPS (dil.) | $2.31 | +188.8% | – |
| EPS (basic) | $2.33 | +187.7% | – |
| Op margin | 4.4% | +2.0pp | |
| Net margin | 2.8% | +1.8pp |
| Metric | Value | Period | Specificity | vs Prior |
|---|---|---|---|---|
| adjusted_earnings_per_share | $7.90 to $8.10 | FY2026 | tight_range | Raised |
| cash_flow_from_operations | at least $11.5 billion | FY2026 | directional | Raised |
| adjusted_earnings_per_share | at least $8.44 | FY2027 | directional | New |
| adjusted_operating_income | $5.03 billion to $5.37 billion | FY2026 | tight_range | Lowered |
| medical_benefit_ratio | 89.75%, plus or minus 25 basis points | FY2026 | tight_range | New |
| adjusted_operating_income | at least $6.4 billion | FY2026 | directional | Raised |
| enterprise_adjusted_operating_income | $16.58 billion to $16.92 billion | FY2026 | tight_range | Raised |
| cash_flow_from_operations | at least $11.5 billion | FY2026 | directional | Raised |
| Q1 FY26 | YoY | |
|---|---|---|
| Revenue | $100.4B1 | +6.2% |
| Net income | $3.0B | +65.9% |
| Op income | $4.7B | +38.7% |
| EPS (dil.) | $2.30 | +63.1% |
| EPS (basic) | $2.31 | +63.8% |
| Op margin | 4.7% | +1.1pp |
| Net margin | 2.9% | +1.1pp |
| Q4 FY25 | YoY | FY25 | |
|---|---|---|---|
| Revenue | $105.7B | +8.2% | $402.1B |
| Net income | $2.9B | 0.0% | – |
| Op income | $2.1B | 0.0% | – |
| EPS (dil.) | $2.30 | +76.9% | – |
| EPS (basic) | – | – | – |
| Op margin | 2.0% | -0.4pp | |
| Net margin | 2.8% | +1.1pp |
| Q3 FY25 | YoY | 9M FY25 | |
|---|---|---|---|
| Revenue | $102.9B | +7.8% | $296.4B |
| Net income | $-4.0B | -5728.2% | $-1.2B |
| Op income | $-3.2B | -485.3% | $2.5B |
| EPS (dil.) | $-3.13 | -4571.4% | $-0.93 |
| EPS (basic) | $-3.13 | -4571.4% | $-0.93 |
| Op margin | -3.1% | -4.0pp | |
| Net margin | -3.9% | -4.0pp |
| Q2 FY25 | YoY | 6M FY25 | |
|---|---|---|---|
| Revenue | $98.9B | +8.4% | $193.5B |
| Net income | $1.0B | -42.7% | $2.8B |
| Op income | $2.4B | -21.8% | $5.8B |
| EPS (dil.) | $0.80 | -43.3% | $2.21 |
| EPS (basic) | $0.81 | -42.5% | $2.22 |
| Op margin | 2.4% | -0.9pp | |
| Net margin | 1.0% | -0.9pp |
| Q1 FY25 | YoY | |
|---|---|---|
| Revenue | – | – |
| Net income | – | – |
| Op income | – | – |
| EPS (dil.) | – | – |
| EPS (basic) | – | – |
| Q4 FY24 | YoY | |
|---|---|---|
| Revenue | – | – |
| Net income | – | – |
| Op income | – | – |
| EPS (dil.) | – | – |
| EPS (basic) | – | – |
| Q3 FY24 | YoY | |
|---|---|---|
| Revenue | – | – |
| Net income | – | – |
| Op income | – | – |
| EPS (dil.) | – | – |
| EPS (basic) | – | – |
| Filing | Date | Period | Sections | Tables |
|---|---|---|---|---|
| 8-K | 2026-08-05 | Q2 2026 | 11 | 0 |
| 10-Q | 2026-08-05 | – | 32 | 70 |
| 8-K | 2026-05-18 | – | 2 | 0 |
| 8-K | 2026-05-06 | Q1 2026 | 11 | 0 |
| 10-Q | 2026-05-06 | – | 32 | 65 |
| DEF 14A | 2026-04-03 | – | 12 | 0 |
| 8-K | 2026-03-19 | – | 1 | 0 |
| 8-K | 2026-02-10 | Q4 2025 | 10 | 0 |
| 10-K | 2026-02-10 | – | 60 | 128 |
| 8-K | 2026-02-05 | – | 2 | 0 |
Showing the latest 10 of 66 — the full set is in the API.